ZNTL
Zentalis Pharmaceuticals
$2.06
+$0.08 (+4.04%)Oct 28, 2026
Key metrics
The numbers that frame ZNTL today
- Market cap
- $147.64M
- ROIC
- -59.3%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $1.21
- 52wk High
- $6.95
Growth
Revenue and earnings trend for ZNTL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ZNTL
Is Zentalis Pharmaceuticals a good buy?
No. Zentalis Pharmaceuticals has weak quality and mixed momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Zentalis Pharmaceuticals is selling at a very high price.
What is the market capitalization of ZNTL?
Zentalis Pharmaceuticals's market capitalization is $147.64M.
What is the 52-week high for ZNTL stock?
The 52-week high for Zentalis Pharmaceuticals is $6.95. The current close of $2.06 is 70.4% below that high.
What is the 52-week low for ZNTL stock?
The 52-week low for Zentalis Pharmaceuticals is $1.21. The current close of $2.06 is 70% above that low.
Does ZNTL stock pay dividends?
Zentalis Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ZNTL?
Zentalis Pharmaceuticals's Debt / Equity ratio is 0.23.